Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA)

Journal of Forensic Sciences

Volumn 49, Issue 5, 2004, Pages 1106-1112

  Kalasinsky, Kathryn S ^a   Hugel, John ^b   Kish, Stephen J ^c  

^a Off of Armed Forces Med Examiner   (United States)

^b HEALTH CANADA   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Addiction; Amphetamine; Ecstasy; Forensic science; Forensic toxicology; MDA; MDMA; Methamphetamine

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 BROMO 2,5 DIMETHOXYPHENETHYLAMINE; 4 METHOXYAMPHETAMINE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; CAFFEINE; COCAINE; DEXTROMETHORPHAN; DIMENHYDRINATE; DIMETHYL SULFONE; EPHEDRINE; GUAIFENESIN; KETAMINE; LEVORPHANOL; METHAMPHETAMINE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; N METHYL 4 METHOXYAMPHETAMINE; PARACETAMOL; PHENCYCLIDINE; PHENETHYLAMINE DERIVATIVE; PSEUDOEPHEDRINE; UNCLASSIFIED DRUG;

ADULT; CANADA; CHEMICAL STRUCTURE; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG ANALYSIS; DRUG DEPENDENCE; DRUG HAIR LEVEL; FEMALE; FORENSIC SCIENCE; GAS CHROMATOGRAPHY; HAIR ANALYSIS; HUMAN; HUMAN TISSUE; LABORATORY; MALE; MASS SPECTROMETRY; NEUROTOXICITY; PRIORITY JOURNAL; SCALP HAIR; TABLET; TOXICOLOGY;

EID: 4444293594     PISSN: 00221198     EISSN: None     Source Type: Journal    
DOI: 10.1520/jfs2003401     Document Type: Conference Paper

References (38)

1. Kalant H. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. CMAJ 2001;165:917-28.
2. Mas M, Farre M, de la Torre R, Roset PN, Ortuno J, Segura J, et al. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 1999;290:136-45.
3. de la Torre R, Farre M, Ortuno J, Mas M, Brenneisen R, Roset PN, et al. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br J Clin Pharmacol 2000;49:104-9.
4. Pizarro N, Ortuno J, Farre M, Hernandez-Lopez C, Pujadas M, Llebaria A, et al. Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis. J Anal Toxicol 2002;26:157-65.
5. Richards KC, Borgstedt HH. Near fatal reaction to ingestion of the hallucinogenic drug MDA. JAMA 1971;218:1826-7.
6. Richards RN. Experience with MDA. CMAJ 1972;106:256-9.
7. Simpson DL, Rumack BH. Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology. Arch Intern Med 1981;141(11):1507-9.
8. Cimbura G. 3,4-methylenedioxyamphetamine (MDA): analytical and forensic aspects of fatal poisoning. J Forensic Sci 1972;17:329-33.
9. Lukaszewski T. 3,4-methylenedioxyamphetamine overdose. Clin Toxicol 1979;15:405-9.
10. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 1992;340:384-7.
11. Mueller PD, Korey WS. Death by "ecstasy": the serotonin syndrome? Ann Emerg Med 1998;32:377-80.
12. Fineschi V, Centini F, Mazzeo E, Turillazzi E. Adam (MDMA) and Eve (MDEA) misuse: an immunohistochemical study on three fatal cases. Forensic Sci Int 1999;104:65-74.
13. Watson JD, Ferguson C, Hinds CJ, Skinner R, Coakley JH. Exertional heat stroke induced by amphetamine analogues. Does dantrolene have a place? Anaesthesia 1993;48:1057-60.
14. Gill JR, Hayes JA, deSouza IS, Marker E, Stajic M. Ecstasy (MDMA) deaths in New York City: a case series and review of the literature. J Forensic Sci 2002;47:121-6.
15. Kish SJ. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacol Biochem Behav 2002;71:845-55.
16. McCann UD, Szabo Z, Scheffel U, Dannals DF, Ricaurte GA. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet 1998;352:1433-7.
17. Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, et al. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 2001;358:1864-9.
18. Parrott AC. Human psychopharmacology of ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol 2001;16:557-77.
19. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology 2004;173:234-241.
20. Chu T, Kumagai Y, DiStefano EW, Cho AK. Disposition of methylene-dioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Biochem Pharmacol 1996;51:789-96.
21. De Letter EA, Clauwaert KM, Belpaire FM, Lambert WE, Van Bocxlaer JF, Piette MH. Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rabbit. Part 1: experimental approach after in vivo intravenous infusion. Int J Legal Med 2002;116:216-24.
22. Zhao H, Brenneisen R, Scholer A, McNally AJ, ElSohly MA, Murphy TP, et al. Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS. J Anal Toxicol 2001 May-Jun;25(4):258-69.
23. Kunsman GW, Levine B, Kuhlman JJ, Jones RL, Hughes RO, Fujiyama CI, et al. MDA-MDMA concentrations in urine specimens. J Anal Toxicol 1996;20:517-21.
24. Cooper GA, Allen DL, Scott KS, Oliver JS, Ditton J, Smith ID. Hair analysis: self-reported use of "speed" and "ecstasy" compared with laboratory findings. J Forensic Sci 2000;45:400-6.
25. Kintz P, Cirimele V, Tracqui A, Mangin P. Simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxy-methamphetamine in human hair by gas chromatography-mass spectrometry. J Chromatogr B Biomed Appl 1995;670:162-6.
26. Kikura R, Nakahara Y, Mieczkowski T, Tagliaro F. Hair analysis for drug abuse. XV. Disposition of 3,4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse. Forensic Sci Int 1997;84:165-77.
27. Rothe M, Pragst F, Spiegel K, Harrach T, Fischer K, Kunkel J. Hair concentrations and self-reported abuse history of 20 amphetamine and ecstasy users. Forensic Sci Int 1997;89:111-28.
28. Tagliaro F, De Battisti Z, Groppi A, Nakahara Y, Scarcella D, Valentini R, et al. High sensitivity simultaneous determination in hair of the major constituents of ecstasy (3,4-methylenedioxymethamphetamine, 3,4- methylenedioxyamphetamine and 3,4-methylene-dioxyethylamphetamine) by high-performance liquid chromatography with direct fluorescence detection. J Chromatogr B Biomed Sci Appl 1999;723:195-202.
29. Skender L, Karacic V, Brcic I, Bagaric A. Quantitative determination of amphetamines, cocaine, and opiates in human hair by gas chromatography/mass spectrometry. Forensic Sci Int 2002;125:120-6.
30. Kish SJ, Furukawa Y, Ang L, Vorce SP, Kalasinsky KS. Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user. Neurology 2000;55:294-6.
31. De Letter EA, Clauwaert KM, Lambert WE, Van Bocxlaer JF, De Leenheer AP, Piette MH. Distribution study of 3,4-methylene-dioxymethamphetamine and 3,4-methylenedioxy-amphetamine in a fatal overdose. J Anal Toxicol 2002;26:113-8.
32. Hegadoren KM, Baker GB, Bourin M. 3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans. Neurosci Biobehav Rev 1999;23:539-53.
33. National Drug Monitor 2001 Annual Report. Ecstasy, amphetamines, and related substances.
34. DanceSafe: Lab Pill Testing-Search Results. www.dancesafe.org
35. Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci 1999;44:359-68.
36. Yudko E, Hall HV, McPherson AB. Methamphetamine use. CRC Press, 2003.
37. Ricaurte G, Bryan G, Strauss L, Seiden L, Schuster C. Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 1985;229:986-8.
38. Ricaurte GA, Yuan J, Hatzidmitriou G, Cord BJ, McCann UD. Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy"). Science 2002;297:2260-63.